Skip to main content

Zealand Pharma to Present Data at the American Diabetes Association’s 2026 Scientific Sessions

Press release – No. 10 / 2026 Zealand Pharma to Present Data atthe American Diabetes Association’s 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster sessions Copenhagen, Denmark, May 27, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announced that data from its obesity and metabolic health pipeline will be presented at the 2026 Scientific Sessions of the American Diabetes Association® (ADA) taking place June 5–8, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. “The ADA’s Scientific Sessions is one of the most significant global scientific platforms highlighting innovation in metabolic health, and we look forward to sharing additional...

Continue reading

Trident Resources Intersects Additional High-Grade Gold at Contact Lake Grading 17.88 g/t Au over 11.25m, including 42.53 g/t over 4.50m from 86m Depth

Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSXV: ROCK) (OTCQB: TRDTF) (Frankfurt: 6BP0) (“Trident” or the “Company”) is pleased to announce assay results for 8 (eight) diamond drill holes from the 2026 winter drill program at the Contact Lake Gold Project in northern Saskatchewan. All eight holes reported herein were collared on the ice at Contact Lake to target gold mineralization in the BK3 Zone, an area that hosts broad mineralized intervals with well-developed, high-grade gold cores several hundred metres to the east-northeast of the previous mine workings. Contact Lake Gold Property Map:http://www.tridentresourcescorp.com/_resources/maps/contact-lake-property-map.jpg Highlights:Hole CL26042 returned 17.88 g/t gold (Au) over 11.25m from 86.00mincluding 31.36 g/t Au over 6.25m from 91.00m including...

Continue reading

Partial restart of mineral sands production in Senegal at approximately 30% of nameplate capacity

Paris, May 27th, 2026, 8:30 amPRESS RELEASE Partial restart of mineral sands production in Senegal at approximately 30% of nameplate capacityPartial restart of HMC (Heavy Mineral Concentrate) production at approximately 30% of nameplate capacity since end of AprilNew production guidance expected between 300 and 400 kt-HMC in 2026Partial resumption of finished products production and first shipments as early as this summer, subject to available HMC inventoryLaunch of reconstruction works for the damaged facilities, aiming to reach 100% of nameplate HMC production capacity in Q1 2027Force majeure provisions applicable to customer and supplier contracts remain in effect as of todayThree months after the fire that occurred on 22 February 2026 at the WCP (Wet Concentration Plant) of the Eramet Grande Côte (« EGC ») site, Eramet...

Continue reading

Leading Edge Materials Moves to 90% Share of Romanian Exploration JV with Comprehensive Underground Exploration Programme Planned at Avram Iancu

LEADING EDGE MATERIALS MOVES TO 90% SHARE OF ROMANIAN EXPLORATION JV WITH COMPREHENSIVE UNDERGROUND EXPLORATION PROGRAMME PLANNED AT AVRAM IANCULeading Edge Materials increases its interest in the Romanian Exploration JV to 90%, reflecting eight years of sustained investment in the Bihor Sud Exploration Licence. New investment discussions underway to directly fund LEM Romania and the upcoming work programme at Avram Iancu. Underground exploration targets Polymetallic and Cobalt-Nickel mineralisation visible over an area of approximately 2 km by 300 metres.Vancouver, May 26, 2026 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) has increased its stake in the Bihor Sud Exploration Licence joint venture to 90%, following an amendment to the...

Continue reading

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Long-term follow up data from the Phase 1 study of pevifoscorvir sodium continues to suggest a reduction in the cccDNA reservoir Data on the preclinical characteristics of the Aligos/Amoytop ASO program to be presented 40% of HBeAg+ participants with chronic HBV infection treated with pevifoscorvir sodium at week 48 had reductions in HBsAg that would potentially allow them to qualify for ASO treatmentSOUTH SAN FRANCISCO, Calif., May 27, 2026 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from ten presentations at the European Association for the Study of the Liver (EASL) Congress 2026, being held May 27 – 30, 2026 in Barcelona, Spain. “We are...

Continue reading

SCOR announces the launch of a cash tender offer and its intention to issue new subordinated notes

   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS PRESS RELEASE. Press release27 May 2026 – N° 9 SCOR announces the launch of a cash tender offer and its intention to issue new subordinated notes SCOR SE (the “Company”) announces the launch of a cash tender offer (the “Tender Offer”) to purchase its EUR 250,000,000 Fixed to Reset Rate Subordinated Notes due...

Continue reading

Societe Generale: Description of the share buy-back programme, subject to approval by the 2026 Annual General Meeting

DESCRIPTION OF THE SHARE BUY-BACK PROGRAMME, SUBJECT TO APPROVAL BY THE 2026 ANNUAL GENERAL MEETING Regulated Information Paris, 27 May 2026 Societe Generale publishes today the description of the share buy-back programme, available below, whose authorisation will be proposed to the Combined Shareholders’ Meeting of 27 May 2026 (18th resolution). Press contacts:Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.com Fanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.com DESCRIPTION OF THE SHARE BUY-BACK PROGRAMMESUBJECT TO APPROVAL BY THE COMBINED GENERAL MEETING DATED 27 MAY 2026 This description is drawn up in accordance with the provisions of Article 241-2, I, of the General Regulation of the French Financial Markets Authority (“Autorité des marches financiers”). 1. Purposes of the share buy-back programmeSociete...

Continue reading

Civinity, AB continues its bond programme: a new tranche of the bond issue, aimed at financing the Group’s further expansion, will total up to EUR 15 million

Civinity, AB is launching the offering of a new bond issue tranche of up to EUR 15 million under the prospectus approved by the Bank of Lithuania on 18 July 2025 for the issue of up to EUR 50 million in bonds (ISIN LT0000134413) and their admission to trading on Nasdaq’s regulated market. This is a further step by Civinity Group in the capital markets, seeking to use funds raised through the bonds to finance the company’s acquisitions. Summary of the key offering terms:issue size – up to EUR 15 million; nominal value of one bond – EUR 1,000; interest rate – 10%; yield – 9.5% or 10%, depending on the purchase price of one bond selected by the investor; offering period – from 27 May 2026 to 10 June 2026; minimum subscription amount – 1 bond.Investors wishing to submit subscription orders for the bonds should contact their bank or financial...

Continue reading

Update of share buy-back programme ForFarmers

Lochem, 27th of May 2026 Update of share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 78,097 shares in the period from 20 May 2026 through 26 May 2026. The shares were repurchased at an average price of €6.42 per share, for a total amount of €501,264. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 16 April 2026. The authorisation concerns the buy-back of shares for ForFarmers to fulfil its obligations arising from (depositary receipts for) share-related incentive schemes. It concerns a maximum of 300,000 shares, for a maximum amount of €2,200,000. The total number of shares that has been repurchased to date according to these programmes is 160,474 shares, for a total amount of €1,028,935. More information about the share...

Continue reading

Navios Maritime Partners L.P. – Successful Senior Unsecured Bond Tap Issue

PIRAEUS, Greece, May 27, 2026 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (the “Company”) announced today that it has successfully completed a USD 30 million tap issue of its outstanding senior unsecured bond due November 7, 2030 (ISIN: NO0013685115). The tap issue was priced at 102.75% of par and was initiated by a reverse inquiry. The net proceeds from the tap issue are intended to be applied towards general corporate purposes. Arctic Securities and Fearnley Securities acted as joint bookrunners, and S. Goldman Advisors LLC acted as Co-Manager, in connection with the placement of the tap issue. About Navios Maritime Partners L.P. Navios Maritime Partners L.P. (NYSE: NMM) is an international owner and operator of dry cargo and tanker vessels. For more information, please visit our website at www.navios-mlp.com. Forward-Looking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.